Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Potential drug discovery for Leishmaniasis

29.09.2004


The scientist who identified the target for several drugs used to treat sleeping sickness and Chagas’ disease has just discovered that antimonial drugs used to treat Leishmaniasis attack the same target.



And, he is "highly optimistic" that research on the parasite molecule "trypanothione", and enzymes that use trypanothione, will lead to a drug that will cure all three tropical diseases.

Professor Alan Fairlamb at the University of Dundee has worked out how the sulphur containing compound trypanothione allows these parasites to fend off free radicals and other toxic oxidants produced by the immune system of the infected patient. Antimonial drugs effectively neutralise the leishmania parasite’s antioxidant defence system, allowing the patient to clear the infection. This may explain why so many patients co-infected with HIV fail to respond well to treatment with antimonials.


Alan discovered and named the "trypanothione" compound in 1985. Together with his team they have now worked that trypanothione is vital for parasite survival and now know several enzymes that new drugs will need to target, including one related to a cancer drug target. The drug discovery and development process usually takes between 7 and 12 years but Alan believes it will be more rapid once they move the project into the new Centre for Interdisciplinary Research at the University of Dundee. The new centre, due to open in 2005 with new facilities in high throughput screening and medicinal chemistry will take the drug process further than any other UK university can and to a stage where the pharmaceutical companies will have enough data move it to the production stage.

"Many cases of leishmaniasis in India are now proving resistant to the traditional antimony drugs so new modern drugs are needed soon", explains Professor Fairlamb. "Resistance to antimonials also involves trypanothione" and he plans for his team to also investigate how they can use their discovery to reverse resistance to antimonials until better, safer drugs are developed.

Recent health reports on US soldiers returning home from Iraq with the Leishmaniasis tropical disease has drawn interest to the killer that has 12 million sufferers worldwide. Commonly brought to the attention of Western countries after a war, tropical diseases are not well funded by the pharmaceutical industry as most of their sufferers are in the developing world which is not a profitable market for sales.

Jenny Marra | alfa
Further information:
http://www.dundee.ac.uk

More articles from Health and Medicine:

nachricht Antibiotic effective against drug-resistant bacteria in pediatric skin infections
17.02.2017 | University of California - San Diego

nachricht Tiny magnetic implant offers new drug delivery method
14.02.2017 | University of British Columbia

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Biocompatible 3-D tracking system has potential to improve robot-assisted surgery

17.02.2017 | Medical Engineering

Real-time MRI analysis powered by supercomputers

17.02.2017 | Medical Engineering

Antibiotic effective against drug-resistant bacteria in pediatric skin infections

17.02.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>